Wealth Enhancement Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$572K	Sell	13,839 -1,757	-11%	-$56K	﹤0.01%	2564
2026 Q1	$427K	Sell	15,596 -25,460	-62%	-$746K	﹤0.01%	2459
2025 Q4	$1.29M	Buy	41,056 +23,662	+136%	+$710K	﹤0.01%	1795
2025 Q3	$522K	Buy	17,394 +668	+4%	+$16.9K	﹤0.01%	2335
2025 Q2	$425K	Sell	16,726 -12,203	-42%	-$267K	﹤0.01%	2344
2025 Q1	$601K	Sell	28,929 -3,429	-11%	-$86.1K	﹤0.01%	1914
2024 Q4	$762K	Sell	32,358 -6,910	-18%	-$170K	﹤0.01%	1700
2024 Q3	$1.01M	Sell	39,268 -5,156	-12%	-$131K	﹤0.01%	1395
2024 Q2	$1.04M	Buy	44,424 +4,305	+11%	+$109K	﹤0.01%	1262
2024 Q1	$1.15M	Sell	40,119 -7,241	-15%	-$218K	﹤0.01%	1170
2023 Q4	$1.55M	Sell	47,360 -24,974	-35%	-$679K	﹤0.01%	989
2023 Q3	$2.02M	Buy	+72,334	New	+$2.36M	0.01%	863

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wealth Enhancement Advisory Services's ARKG Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its ARK Genomic Revolution ETF (ARKG) stake by 11% in Q2 2026, selling an estimated $56K and leaving 13,839 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #2564.

Wealth Enhancement Advisory Services first reported a position in ARKG in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.02M in Q3 2023. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Wealth Enhancement Advisory Services held 13,839 shares of ARK Genomic Revolution ETF worth $572K as of Q2 2026.
Wealth Enhancement Advisory Services sold 1,757 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $56K.
ARK Genomic Revolution ETF made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2564 holding.
Wealth Enhancement Advisory Services first reported a position in ARK Genomic Revolution ETF in Q3 2023 and has held it in 12 quarters since.
Wealth Enhancement Advisory Services's ARK Genomic Revolution ETF position peaked at $2.02M in Q3 2023.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.